AmDerma Report issue

For profit Phase 2 Phase 3
Founded: Bridgewater NJ United States (2010)
Status: Acquired by Amneal Pharmaceuticals (2020)

Organization Overview

First Clinical Trial
2010
NCT00768599
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AmDerma | AmDerma Pharmaceuticals, LLC